Similar articles

• Carbapenem resistance in Bacteroides fragilis.

  Ang L, Brenwald NP, Walker RM, Andrews J, Fraise A. Ang L, et al. J Antimicrob Chemother. 2007 May;59(5):1042-4. doi: 10.1093/jac/dkm062. Epub 2007 Mar 15. J Antimicrob Chemother. 2007. PMID: 17363423 No abstract available.
• Examination of cfiA-mediated carbapenem resistance in Bacteroides fragilis strains from a European antibiotic susceptibility survey.

  Sóki J, Edwards R, Hedberg M, Fang H, Nagy E, Nord CE; ESCMID Study Group on Antimicrobial Resistance in Anaerobic Bacteria. Sóki J, et al. Int J Antimicrob Agents. 2006 Dec;28(6):497-502. doi: 10.1016/j.ijantimicag.2006.07.021. Epub 2006 Nov 13. Int J Antimicrob Agents. 2006. PMID: 17097857
• In vitro activities of MK-0826 and 16 other antimicrobials against Bacteroides fragilis group strains.

  Betriu C, Sánchez A, Palau ML, Gómez M, Picazo JJ. Betriu C, et al. Antimicrob Agents Chemother. 2001 Aug;45(8):2372-4. doi: 10.1128/AAC.45.8.2372-2374.2001. Antimicrob Agents Chemother. 2001. PMID: 11451700 Free PMC article.
• Carbapenem resistance in Bacteroides fragilis: A review of molecular mechanisms.

  Yekani M, Rezaee MA, Beheshtirouy S, Baghi HB, Bazmani A, Farzinazar A, Memar MY, Sóki J. Yekani M, et al. Anaerobe. 2022 Aug;76:102606. doi: 10.1016/j.anaerobe.2022.102606. Epub 2022 Jun 20. Anaerobe. 2022. PMID: 35738484 Review.
• Newer beta-lactam agents and the Bacteroides fragilis group.

  Cuchural GJ Jr. Cuchural GJ Jr. Pharmacotherapy. 1991;11(2 ( Pt 2)):51S-55S. Pharmacotherapy. 1991. PMID: 2041832 Review.